{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T01:19:27Z","timestamp":1787534367041,"version":"build-2736575974"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75701-6","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:35:20Z","timestamp":1784622920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fluorofenidone ameliorates pressure overload-induced heart failure by stabilizing SERCA2a in male mice"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2585-0960","authenticated-orcid":false,"given":"Quan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiantao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongxin","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7809-6821","authenticated-orcid":false,"given":"Li","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suiqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adilai","family":"Maihemuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilin","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaizheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9722-9375","authenticated-orcid":false,"given":"Kangni","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5005-327X","authenticated-orcid":false,"given":"Mengya","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1184-1182","authenticated-orcid":false,"given":"Zhongkai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"75701_CR1","first-page":"e41","volume":"151","author":"SS Martin","year":"2025","unstructured":"Martin, S. S. et al. 2025 Heart disease and stroke statistics: a report of US and Global data from the American Heart Association. Circulation 151, e41\u2013e660 (2025).","journal-title":"Circulation"},{"key":"75701_CR2","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R. & Abel, E. D. Cardiac energy metabolism in heart failure. Circ. Res 128, 1487\u20131513 (2021).","journal-title":"Circ. Res"},{"key":"75701_CR3","doi-asserted-by":"publisher","first-page":"a035428","DOI":"10.1101\/cshperspect.a035428","volume":"12","author":"G Gilbert","year":"2020","unstructured":"Gilbert, G. et al. Calcium signaling in cardiomyocyte function. Cold Spring Harb. Perspect. Biol. 12, a035428 (2020).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"75701_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ejhf.3024","volume":"26","author":"Authors\/Task","year":"2024","unstructured":"Authors\/Task et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail 26, 5\u201317 (2024).","journal-title":"Eur. J. Heart Fail"},{"key":"75701_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10741-019-09873-3","volume":"25","author":"L Zhihao","year":"2020","unstructured":"Zhihao, L. et al. SERCA2a: a key protein in the Ca(2+) cycle of the heart failure. Heart Fail Rev. 25, 523\u2013535 (2020).","journal-title":"Heart Fail Rev."},{"key":"75701_CR6","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.111.259754","volume":"110","author":"EG Kranias","year":"2012","unstructured":"Kranias, E. G. & Hajjar, R. J. Modulation of cardiac contractility by the phospholamban\/SERCA2a regulatome. Circ. Res 110, 1646\u20131660 (2012).","journal-title":"Circ. Res"},{"key":"75701_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek, K. N. & Komander, D. Ubiquitin modifications. Cell Res 26, 399\u2013422 (2016).","journal-title":"Cell Res"},{"key":"75701_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41580-024-00778-0","volume":"26","author":"C Arkinson","year":"2025","unstructured":"Arkinson, C., Dong, K. C., Gee, C. L. & Martin, A. Mechanisms and regulation of substrate degradation by the 26S proteasome. Nat. Rev. Mol. Cell Biol. 26, 104\u2013122 (2025).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"75701_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06380-0","volume":"14","author":"A Behera","year":"2023","unstructured":"Behera, A. & Reddy, A. B. M. WWP1 E3 ligase at the crossroads of health and disease. Cell Death Dis. 14, 853 (2023).","journal-title":"Cell Death Dis."},{"key":"75701_CR10","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.7150\/ijbs.48437","volume":"16","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. E3 Ubiquitin ligase NEDD4 familyregulatory network in cardiovascular disease. Int J. Biol. Sci. 16, 2727\u20132740 (2020).","journal-title":"Int J. Biol. Sci."},{"key":"75701_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12929-021-00731-9","volume":"28","author":"L Sun","year":"2021","unstructured":"Sun, L., Amraei, R. & Rahimi, N. NEDD4 regulates ubiquitination and stability of the cell adhesion molecule IGPR-1 via lysosomal pathway. J. Biomed. Sci. 28, 35 (2021).","journal-title":"J. Biomed. Sci."},{"key":"75701_CR12","doi-asserted-by":"publisher","first-page":"757493","DOI":"10.3389\/fcell.2021.757493","volume":"9","author":"L Kuang","year":"2021","unstructured":"Kuang, L., Jiang, Y., Li, C. & Jiang, Y. WW Domain-Containing E3 Ubiquitin Protein Ligase 1: A Self-Disciplined Oncoprotein. Front Cell Dev. Biol. 9, 757493 (2021).","journal-title":"Front Cell Dev. Biol."},{"key":"75701_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41392-021-00660-x","volume":"6","author":"C Liao","year":"2021","unstructured":"Liao, C. et al. WWP1 targeting MUC1 for ubiquitin-mediated lysosomal degradation to suppress carcinogenesis. Signal Transduct. Target Ther. 6, 297 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"75701_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1161\/CIRCULATIONAHA.121.054827","volume":"144","author":"D Zhao","year":"2021","unstructured":"Zhao, D. et al. Targeting E3 Ubiquitin Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination. Circulation 144, 694\u2013711 (2021).","journal-title":"Circulation"},{"key":"75701_CR15","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3390\/molecules17010884","volume":"17","author":"Q Lou","year":"2012","unstructured":"Lou, Q. et al. Design, synthesis and antifibrotic activities of carbohydrate-modified 1-(substituted aryl)-5-trifluoromethyl-2(1H) pyridones. Molecules 17, 884\u2013896 (2012).","journal-title":"Molecules"},{"key":"75701_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/nep.12128","volume":"18","author":"J Qin","year":"2013","unstructured":"Qin, J. et al. Fluorofenidone inhibits nicotinamide adeninedinucleotide phosphate oxidase via PI3K\/Akt pathway in the pathogenesis of renal interstitial fibrosis. Nephrol. (Carlton) 18, 690\u2013699 (2013).","journal-title":"Nephrol. (Carlton)"},{"key":"75701_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-2027-8","volume":"17","author":"H Chen","year":"2019","unstructured":"Chen, H. et al. A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis. J. Transl. Med. 17, 280 (2019).","journal-title":"J. Transl. Med."},{"key":"75701_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.31083\/ph.2012.1748","volume":"67","author":"L Chen","year":"2012","unstructured":"Chen, L. et al. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation. Pharmazie 67, 452\u2013456 (2012).","journal-title":"Pharmazie"},{"key":"75701_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3892\/mmr.2021.12044","volume":"23","author":"F Jiang","year":"2021","unstructured":"Jiang, F. et al. Fluorofenidone attenuates paraquat\u2011induced pulmonary fibrosis by regulating the PI3K\/Akt\/mTOR signaling pathway and autophagy. Mol. Med Rep. 23, 405 (2021).","journal-title":"Mol. Med Rep."},{"key":"75701_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.bbrc.2023.09.079","volume":"681","author":"G Avila","year":"2023","unstructured":"Avila, G. Fluorofenidone enhances cardiac contractility by stimulating CICR and Ca(V)1.2. Biochem Biophys. Res Commun. 681, 242\u2013248 (2023).","journal-title":"Biochem Biophys. Res Commun."},{"key":"75701_CR21","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1161\/CIRCRESAHA.113.301651","volume":"113","author":"M Luo","year":"2013","unstructured":"Luo, M. & Anderson, M. E. Mechanisms of altered Ca(2)(+) handling in heart failure. Circ. Res 113, 690\u2013708 (2013).","journal-title":"Circ. Res"},{"key":"75701_CR22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","volume":"18","author":"S Mishra","year":"2021","unstructured":"Mishra, S. & Kass, D. A. Cellular and molecular pathobiology of heart failure with preserved ejection fraction. Nat. Rev. Cardiol. 18, 400\u2013423 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"75701_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/9780470559277.ch110180","volume":"3","author":"B Lomenick","year":"2011","unstructured":"Lomenick, B., Jung, G., Wohlschlegel, J. A. & Huang, J. Target identification using drug affinity responsive target stability (DARTS). Curr. Protoc. Chem. Biol. 3, 163\u2013180 (2011).","journal-title":"Curr. Protoc. Chem. Biol."},{"key":"75701_CR24","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/nprot.2014.138","volume":"9","author":"R Jafari","year":"2014","unstructured":"Jafari, R. et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat. Protoc. 9, 2100\u20132122 (2014).","journal-title":"Nat. Protoc."},{"key":"75701_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nchembio.304","volume":"6","author":"T Schneider-Poetsch","year":"2010","unstructured":"Schneider-Poetsch, T. et al. Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat. Chem. Biol. 6, 209\u2013217 (2010).","journal-title":"Nat. Chem. Biol."},{"key":"75701_CR26","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2017.04.023","volume":"169","author":"GA Collins","year":"2017","unstructured":"Collins, G. A. & Goldberg, A. L. The Logic of the 26S Proteasome. Cell 169, 792\u2013806 (2017).","journal-title":"Cell"},{"key":"75701_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/path.2697","volume":"221","author":"D Glick","year":"2010","unstructured":"Glick, D., Barth, S. & Macleod, K. F. Autophagy: cellular and molecular mechanisms. J. Pathol. 221, 3\u201312 (2010).","journal-title":"J. Pathol."},{"key":"75701_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/CIRCRESAHA.122.321849","volume":"132","author":"B Ye","year":"2023","unstructured":"Ye, B. et al. USP25 ameliorates pathological cardiac hypertrophy by stabilizing SERCA2a in cardiomyocytes. Circ. Res 132, 465\u2013480 (2023).","journal-title":"Circ. Res"},{"key":"75701_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nsmb.2780","volume":"21","author":"CE Berndsen","year":"2014","unstructured":"Berndsen, C. E. & Wolberger, C. New insights into ubiquitin E3 ligase mechanism. Nat. Struct. Mol. Biol. 21, 301\u2013307 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"75701_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau0159","volume":"364","author":"YR Lee","year":"2019","unstructured":"Lee, Y. R. et al. Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway. Science 364, eaau0159 (2019).","journal-title":"Science"},{"key":"75701_CR31","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrm.2016.91","volume":"17","author":"L Buetow","year":"2016","unstructured":"Buetow, L. & Huang, D. T. Structural insights into the catalysis and regulation of E3 ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 17, 626\u2013642 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"75701_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev-biochem-030222-120000","volume":"93","author":"JM Paggi","year":"2024","unstructured":"Paggi, J. M., Pandit, A. & Dror, R. O. The art and science of molecular docking. Annu Rev. Biochem 93, 389\u2013410 (2024).","journal-title":"Annu Rev. Biochem"},{"key":"75701_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1172\/JCI62834","volume":"123","author":"AR Marks","year":"2013","unstructured":"Marks, A. R. Calcium cycling proteins and heart failure: mechanisms and therapeutics. J. Clin. Invest 123, 46\u201352 (2013).","journal-title":"J. Clin. Invest"},{"key":"75701_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura, M. & Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol. 15, 387\u2013407 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"75701_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/cvr\/cvm063","volume":"77","author":"V Bito","year":"2008","unstructured":"Bito, V., Heinzel, F. R., Biesmans, L., Antoons, G. & Sipido, K. R. Crosstalk between L-type Ca2+ channels and the sarcoplasmic reticulum: alterations during cardiac remodelling. Cardiovasc Res 77, 315\u2013324 (2008).","journal-title":"Cardiovasc Res"},{"key":"75701_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10741-024-10395-w","volume":"29","author":"YB Liu","year":"2024","unstructured":"Liu, Y. B. et al. Abnormal phosphorylation \/ dephosphorylation and Ca(2+) dysfunction in heart failure. Heart Fail Rev. 29, 751\u2013768 (2024).","journal-title":"Heart Fail Rev."},{"key":"75701_CR37","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41569-020-0394-8","volume":"17","author":"H Dridi","year":"2020","unstructured":"Dridi, H. et al. Intracellular calcium leak in heart failure and atrial fibrillation: a unifying mechanism and therapeutic target. Nat. Rev. Cardiol. 17, 732\u2013747 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"75701_CR38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1113\/JP283082","volume":"601","author":"KT MacLeod","year":"2023","unstructured":"MacLeod, K. T. Changes in cellular Ca(2+) and Na(+) regulation during the progression towards heart failure. J. Physiol. 601, 905\u2013921 (2023).","journal-title":"J. Physiol."},{"key":"75701_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/cvr\/cvv205","volume":"108","author":"MY Rincon","year":"2015","unstructured":"Rincon, M. Y., VandenDriessche, T. & Chuah, M. K. Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation. Cardiovasc Res 108, 4\u201320 (2015).","journal-title":"Cardiovasc Res"},{"key":"75701_CR40","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jtcvs.2015.11.031","volume":"151","author":"MG Katz","year":"2016","unstructured":"Katz, M. G. et al. Mitigation of myocardial fibrosis by molecular cardiac surgery-mediated gene overexpression. J. Thorac. Cardiovasc Surg. 151, 1191\u2013200.e3 (2016).","journal-title":"J. Thorac. Cardiovasc Surg."},{"key":"75701_CR41","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/CIRCULATIONAHA.108.770883","volume":"118","author":"F Prunier","year":"2008","unstructured":"Prunier, F. et al. Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2+ ATPase pump overexpression in a porcine model of ischemia reperfusion. Circulation 118, 614\u2013624 (2008).","journal-title":"Circulation"},{"key":"75701_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/01.RES.81.2.145","volume":"81","author":"RJ Hajjar","year":"1997","unstructured":"Hajjar, R. J., Schmidt, U., Kang, J. X., Matsui, T. & Rosenzweig, A. Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circ. Res 81, 145\u2013153 (1997).","journal-title":"Circ. Res"},{"key":"75701_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cardfail.2009.01.013","volume":"15","author":"BE Jaski","year":"2009","unstructured":"Jaski, B. E. et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1\/2 clinical trial. J. Card. Fail 15, 171\u2013181 (2009).","journal-title":"J. Card. Fail"},{"key":"75701_CR44","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","volume":"387","author":"B Greenberg","year":"2016","unstructured":"Greenberg, B. et al. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial. Lancet 387, 1178\u20131186 (2016).","journal-title":"Lancet"},{"key":"75701_CR45","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10741-025-10487-1","volume":"30","author":"AK Shooshtarian","year":"2025","unstructured":"Shooshtarian, A. K., O\u2019Gallagher, K., Shah, A. M. & Zhang, M. SERCA2a dysfunction in the pathophysiology of heart failure with preserved ejection fraction: a direct role is yet to be established. Heart Fail Rev. 30, 545\u2013564 (2025).","journal-title":"Heart Fail Rev."},{"key":"75701_CR46","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.1073\/pnas.94.12.6438","volume":"94","author":"MN Sack","year":"1997","unstructured":"Sack, M. N., Disch, D. L., Rockman, H. A. & Kelly, D. P. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. Proc. Natl. Acad. Sci. USA 94, 6438\u20136443 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75701_CR47","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/CIRCRESAHA.117.312117","volume":"122","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. LncRNA ZFAS1 as a SERCA2a Inhibitor to Cause Intracellular Ca(2+) Overload and Contractile Dysfunction in a Mouse Model of Myocardial Infarction. Circ. Res 122, 1354\u20131368 (2018).","journal-title":"Circ. Res"},{"key":"75701_CR48","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1161\/CIRCRESAHA.119.316061","volume":"127","author":"D Han","year":"2020","unstructured":"Han, D. et al. The tumor-suppressive human circular RNA CircITCH sponges miR-330-5p to ameliorate doxorubicin-induced cardiotoxicity through upregulating SIRT6, Survivin, and SERCA2a. Circ. Res 127, e108\u2013e125 (2020).","journal-title":"Circ. Res"},{"key":"75701_CR49","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jmb.2006.02.051","volume":"358","author":"CB Karim","year":"2006","unstructured":"Karim, C. B., Zhang, Z., Howard, E. C., Torgersen, K. D. & Thomas, D. D. Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA. J. Mol. Biol. 358, 1032\u20131040 (2006).","journal-title":"J. Mol. Biol."},{"key":"75701_CR50","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.aad4076","volume":"351","author":"BR Nelson","year":"2016","unstructured":"Nelson, B. R. et al. A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle. Science 351, 271\u2013275 (2016).","journal-title":"Science"},{"key":"75701_CR51","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0006-291X(03)00987-2","volume":"306","author":"R Kiewitz","year":"2003","unstructured":"Kiewitz, R. et al. Ca2+ -dependent interaction of S100A1 with the sarcoplasmic reticulum Ca2+ -ATPase2a and phospholamban in the human heart. Biochem. Biophys. Res Commun. 306, 550\u2013557 (2003).","journal-title":"Biochem. Biophys. Res Commun."},{"key":"75701_CR52","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.120.053365","volume":"144","author":"M Korf-Klingebiel","year":"2021","unstructured":"Korf-Klingebiel, M. et al. Myeloid-Derived Growth Factor Protects Against Pressure Overload-Induced Heart Failure by Preserving Sarco\/Endoplasmic Reticulum Ca(2+)-ATPase Expression in Cardiomyocytes. Circulation 144, 1227\u20131240 (2021).","journal-title":"Circulation"},{"key":"75701_CR53","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nature10407","volume":"477","author":"C Kho","year":"2011","unstructured":"Kho, C. et al. SUMO1-dependent modulation of SERCA2a in heart failure. Nature 477, 601\u2013605 (2011).","journal-title":"Nature"},{"key":"75701_CR54","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1161\/CIRCRESAHA.118.313865","volume":"124","author":"PA Gorski","year":"2019","unstructured":"Gorski, P. A. et al. Role of SIRT1 in Modulating Acetylation of the Sarco-Endoplasmic Reticulum Ca(2+)-ATPase in Heart Failure. Circ. Res. 124, e63\u2013e80 (2019).","journal-title":"Circ. Res."},{"key":"75701_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/01.RES.0000253904.53601.c9","volume":"100","author":"CG Tocchetti","year":"2007","unstructured":"Tocchetti, C. G. et al. Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling. Circ. Res. 100, 96\u2013104 (2007).","journal-title":"Circ. Res."},{"key":"75701_CR56","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41580-022-00543-1","volume":"24","author":"I Dikic","year":"2023","unstructured":"Dikic, I. & Schulman, B. A. An expanded lexicon for the ubiquitin code. Nat. Rev. Mol. Cell Biol. 24, 273\u2013287 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"75701_CR57","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.124.012180","volume":"18","author":"N Yang","year":"2025","unstructured":"Yang, N. et al. Succinylation of SERCA2a at K352 promotes its ubiquitinoylation and degradation by proteasomes in sepsis-induced heart dysfunction. Circ. Heart Fail 18, e012180 (2025).","journal-title":"Circ. Heart Fail"},{"key":"75701_CR58","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3390\/cells11050851","volume":"11","author":"Y Li","year":"2022","unstructured":"Li, Y., Li, S. & Wu, H. Ubiquitination-Proteasome System (UPS) and autophagy two main protein degradation machineries in response to cell stress. Cells 11, 851 (2022).","journal-title":"Cells"},{"key":"75701_CR59","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev-biochem-061516-044908","volume":"86","author":"I Dikic","year":"2017","unstructured":"Dikic, I. Proteasomal and Autophagic Degradation Systems. Annu Rev. Biochem 86, 193\u2013224 (2017).","journal-title":"Annu Rev. Biochem"},{"key":"75701_CR60","doi-asserted-by":"publisher","first-page":"C1050","DOI":"10.1152\/ajpcell.00127.2014","volume":"307","author":"KS Moshal","year":"2014","unstructured":"Moshal, K. S. et al. Progesterone modulates SERCA2a expression and function in rabbit cardiomyocytes. Am. J. Physiol. Cell Physiol. 307, C1050\u2013C1057 (2014).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"75701_CR61","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/ejhf.897","volume":"19","author":"C Tita","year":"2017","unstructured":"Tita, C. et al. A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction. Eur. J. Heart Fail 19, 1321\u20131332 (2017).","journal-title":"Eur. J. Heart Fail"},{"key":"75701_CR62","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1002\/ejhf.1743","volume":"22","author":"V Carubelli","year":"2020","unstructured":"Carubelli, V. et al. Treatment with 24 hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo-controlled trial. Eur. J. Heart Fail 22, 1684\u20131693 (2020).","journal-title":"Eur. J. Heart Fail"},{"key":"75701_CR63","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/ejhf.2629","volume":"24","author":"M Metra","year":"2022","unstructured":"Metra, M. et al. Safety and efficacy of istaroxime in patients with acute heart failure-related pre-cardiogenic shock - a multicentre, randomized, double-blind, placebo-controlled, parallel group study (SEISMiC). Eur. J. Heart Fail 24, 1967\u20131977 (2022).","journal-title":"Eur. J. Heart Fail"},{"key":"75701_CR64","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jchf.2023.02.006","volume":"11","author":"S Sarma","year":"2023","unstructured":"Sarma, S. et al. SERCA2a agonist effects on cardiac performance during exercise in heart failure with preserved ejection fraction. Jacc-Heart Fail 11, 760\u2013771 (2023).","journal-title":"Jacc-Heart Fail"},{"key":"75701_CR65","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1124\/jpet.122.001335","volume":"384","author":"M Arici","year":"2023","unstructured":"Arici, M. et al. Istaroxime metabolite PST3093 selectively stimulates SERCA2a and reverses disease-induced changes in cardiac function. J. Pharm. Exp. Ther. 384, 231\u2013244 (2023).","journal-title":"J. Pharm. Exp. Ther."},{"key":"75701_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04874-9","volume":"22","author":"M Arici","year":"2024","unstructured":"Arici, M. et al. Selective SERCA2a activator as a candidate for chronic heart failure therapy. J. Transl. Med 22, 77 (2024).","journal-title":"J. Transl. Med"},{"key":"75701_CR67","doi-asserted-by":"publisher","first-page":"534775","DOI":"10.3389\/fphar.2020.534775","volume":"11","author":"Q Dai","year":"2020","unstructured":"Dai, Q. et al. Fluorofenidone alleviates renal fibrosis by inhibiting necroptosis through RIPK3\/MLKL pathway. Front Pharm. 11, 534775 (2020).","journal-title":"Front Pharm."},{"key":"75701_CR68","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.intimp.2011.04.016","volume":"11","author":"WB Ning","year":"2011","unstructured":"Ning, W. B. et al. Fluorofenidone inhibits Ang II-induced apoptosis of renal tubular cells through blockage of the Fas\/FasL pathway. Int Immunopharmacol. 11, 1327\u20131332 (2011).","journal-title":"Int Immunopharmacol."},{"key":"75701_CR69","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002402R","volume":"35","author":"S Tu","year":"2021","unstructured":"Tu, S. et al. Fluorofenidone protects liver against inflammation and fibrosis by blocking the activation of NF-\u03baB pathway. FASEB J. 35, e21497 (2021).","journal-title":"FASEB J."},{"key":"75701_CR70","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejphar.2016.01.006","volume":"773","author":"YH Wu","year":"2016","unstructured":"Wu, Y. H. et al. Fluorofenidone attenuates bleomycin-induced pulmonary fibrosis by inhibiting eukaryotic translation initiation factor 3a (eIF3a) in rats. Eur. J. Pharm. 773, 42\u201350 (2016).","journal-title":"Eur. J. Pharm."},{"key":"75701_CR71","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11010-015-2456-5","volume":"407","author":"J Tang","year":"2015","unstructured":"Tang, J. et al. Fluorofenidone protects against renal fibrosis by inhibiting STAT3 tyrosine phosphorylation. Mol. Cell Biochem 407, 77\u201387 (2015).","journal-title":"Mol. Cell Biochem"},{"key":"75701_CR72","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1073\/pnas.1015081108","volume":"108","author":"DJ Cao","year":"2011","unstructured":"Cao, D. J. et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc. Natl. Acad. Sci. USA 108, 4123\u20134128 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75701_CR73","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/19768354.2023.2181217","volume":"27","author":"J Kwon","year":"2023","unstructured":"Kwon, J., Kim, J. & Kim, K. I. Crosstalk between endoplasmic reticulum stress response and autophagy in human diseases. Anim. Cells Syst. 27, 29\u201337 (2023).","journal-title":"Anim. Cells Syst."},{"key":"75701_CR74","doi-asserted-by":"publisher","first-page":"121705","DOI":"10.1016\/j.lfs.2023.121705","volume":"323","author":"S Divya","year":"2023","unstructured":"Divya, S. & Ravanan, P. Cellular battle against endoplasmic reticulum stress and its adverse effect on health. Life Sci. 323, 121705 (2023).","journal-title":"Life Sci."},{"key":"75701_CR75","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/molecules17021373","volume":"17","author":"L Wu","year":"2012","unstructured":"Wu, L. et al. Design, synthesis and anti-fibrosis activity study of N(1)-substituted phenylhydroquinolinone derivatives. Molecules 17, 1373\u20131387 (2012).","journal-title":"Molecules"},{"key":"75701_CR76","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jchromb.2006.01.010","volume":"833","author":"W Cao","year":"2006","unstructured":"Cao, W., He, L., Liu, W., Huang, Z. & Cheng, Z. Determination of AKF-PD in whole blood of rat by HPLC-UV. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 833, 257\u2013259 (2006).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"75701_CR77","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s12265-021-10170-4","volume":"15","author":"H Li","year":"2022","unstructured":"Li, H. et al. A new minimally invasive method of transverse aortic constriction in mice. J. Cardiovasc Transl. Res. 15, 635\u2013643 (2022).","journal-title":"J. Cardiovasc Transl. Res."},{"key":"75701_CR78","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.119.315861","volume":"126","author":"S Ye","year":"2020","unstructured":"Ye, S. et al. Celastrol attenuates angiotensin II-induced cardiac remodeling by targeting STAT3. Circ. Res 126, 1007\u20131023 (2020).","journal-title":"Circ. Res"},{"key":"75701_CR79","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/HYPERTENSIONAHA.118.11357","volume":"72","author":"J Ye","year":"2018","unstructured":"Ye, J. et al. Programmed Cell Death 5 Provides Negative Feedback on Cardiac Hypertrophy Through the Stabilization of Sarco\/Endoplasmic Reticulum Ca(2+)-ATPase 2a Protein. Hypertension 72, 889\u2013901 (2018).","journal-title":"Hypertension"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75701-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75701-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75701-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T01:02:03Z","timestamp":1787533323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75701-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75701"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75701-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8878"}}